Skip to main content
. 2022 Oct 31;10(10):e004235. doi: 10.1136/jitc-2021-004235

Figure 3.

Figure 3

T-cell activity in blood samples of patients treated with INCAGN01949. Fold change from baseline of (A) proliferating (Ki67+) T cells. (B) Activated/exhausted (PD-1+) T cells. (C) Tregs. C, cycle; D, day; PD-1, programmed cell death protein 1; Treg, regulatory T cell.